Key result
Functional class IV linked to ~284% higher 6-month mortality risk in decompensated HF inpatients.
Why the study?
Several parameters have been proposed to objectively measure quality of care and breaches of care in heart failure, prompting an evaluation of quality of care measures in inpatients with decompensated heart failure at a Venezuelan tertiary hospital.
Observational (n=131)
No
Quality of care for decompensated heart failure in a Venezuelan hospital showed high rates of follow-up scheduling and beta-blocker prescription, with increasing adoption of SGLT2 inhibitors and LVEF assessment.
Answers are grounded in this paper and cite their sources.
High adherence to select QoC measures seen in this Venezuelan HF cohort; leaves open whether rising LVEF assessment and iSGLT2 use improve outcomes in resource-limited settings.
Background/Objectives: Several parameters have been proposed for the objective measurement of the quality of care (QoC) and breaches of care in patients with heart failure (HF). Therefore, the objective of this study was to evaluate the measures of QoC in inpatients with decompensated HF in the cardiology department of a tertiary Venezuelan hospital. Methods: An observational, descriptive, ambispective study was conducted with adults of all genders diagnosed with decompensated HF between 2022 and 2024. Sociodemographic, clinical, and therapeutic variables were assessed, as well as psychobiologic habits, measures of QoC, readmissions, and in-hospital mortality within the first 6 months of care. Results: Among the 131 subjects evaluated, the average age was 63.6 ± 14.1 years, with 58% (n = 76) being male. Among the in-hospital measures of QoC, the most common was the programming for follow-up consultations (98.5%; n = 129), followed by the prescription of beta-blockers (90.1%; n = 118). An upwards trend was also observed in the later years regarding the frequency of left ventricle ejection fraction (LVEF) assessment (p < 0.001), and the use of iSGLT2 (p = 0.03). During follow-up, 36.6% of the patients died within 6 months, with those in NYHA class IV showing a higher probability of death (OR: 3.84; CI95%: 0.89–16.55; 0.04). Conclusions: The in-hospital measures for QoC in this population were similar to those in previous reports, with LVEF assessment and iSGLT2 prescription showing a particularly significant increase in recent years.
No takes yet. Share an insight, caveat, or question.
Benítez et al. (2025) conducted an observational in Decompensated heart failure (n=131). NYHA class IV vs. Lower NYHA classes was evaluated on Death within 6 months (OR 3.84, 95% CI 0.89-16.55, p=0.04). Functional class IV was associated with a higher probability of death within 6 months among inpatients with decompensated heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: